For this purpose, prostate (PC3) and breast (MDA-MB-231) adenocarcinoma cells were used as models since they express a significant level of endogenous neuropilin-1 and are known to respond to activation of neuropilin-1-dependent pathways [22–24]. This evidence concerns the gene NRP1 and adenocarcinoma.